HCPCS code C9073 — Brexucabtagene autoleucel ca.
Status: Deleted.
Effective Apr 1, 2021.
Source: CMS HCPCS Level II.
C9073
DeletedBrexucabtagene autoleucel ca
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code C9073 has been deleted from the HCPCS Level II set.
Termination date: Mar 31, 2021. Claims with a date of service on or after this day will be denied under this code.
No successor code has been identified. Consult the CMS HCPCS Update Summary for guidance.
Category:
Outpatient PPS
Section:
C-codes: Outpatient PPS
Effective:
Apr 1, 2021
Terminated:
Mar 31, 2021
Code type:
alphanumeric
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.